Viking Therapeutics completes of enrolment in VENTURE Trial for GLP-1/GIP receptor agonist VK2735 Viking Therapeutics has completed patient enrolment in its Phase 2 clinical trial of VK2735, the company's wholly-owned dual agonist of...
GE HealthCare and Novo Nordisk to collaborate on peripheral focused ultrasound for T2DM and obesityGE HealthCare and Novo Nordisk are collaborating to further advance the clinical and product development of peripheral focused ultrasound...
Bariatric patients regain more weight than non-bariatric patients after body contouring surgeryPatients with previous bariatric surgery who undergo body contouring (BC) regain more weight at long-term follow-up, compared to body...
First commercial use of Levita Magnetics’ MARS Surgical SystemLevita Magnetics has announced the world's first commercial use of its MARS platform. The first commercial use, which took place in...
High rates for breast cancer recurrence for women with obesity Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs...
Hungry brain test identifies abnormal satiation and predicts response to QsymiaResults from a study conducted at Mayo Clinic to assess the utility of the Phenomix Sciences MyPhenome Hungry Brain test has demonstrated...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomesApr 25